2018
DOI: 10.1016/j.cmet.2018.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis

Abstract: Onset of cardiovascular complications as a consequence of atherosclerosis exhibits a circadian incidence with a peak in the morning hours. Although development of atherosclerosis extends for long periods of time through arterial leukocyte recruitment, we hypothesized that discrete diurnal invasion of the arterial wall could sustain atherogenic growth. Here, we show that myeloid cell recruitment to atherosclerotic lesions oscillates with a peak during the transition from the activity to the resting phase. This … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
147
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 163 publications
(156 citation statements)
references
References 29 publications
2
147
0
1
Order By: Relevance
“…For example, disruption of Bmal1 in club cells and adrenalectomy in the context of circadian recruitment of neutrophils to lungs after LPS revealed blunted glucocorticoid signaling, non-rhythmic expression of CXCL5, neutrophilia and antimicrobial responses (65). Other studies tested the possibility of targeting the circadian properties of neutrophils and monocytes in atherosclerosis, by showing arterial-and time-specific repression of leukocyte recruitment to plaques upon inhibition of CCR2 (81). Timed CCR2 blocking at nighttime (ZT17) decreased arterial myeloid cell recruitment and atherosclerotic lesion formation, whereas the neutralization at daytime (ZT5) had no effect, suggesting again the importance of chrono-pharmacology-based approaches (81).…”
Section: Targeting the Circadian Properties Of Neutrophils For Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…For example, disruption of Bmal1 in club cells and adrenalectomy in the context of circadian recruitment of neutrophils to lungs after LPS revealed blunted glucocorticoid signaling, non-rhythmic expression of CXCL5, neutrophilia and antimicrobial responses (65). Other studies tested the possibility of targeting the circadian properties of neutrophils and monocytes in atherosclerosis, by showing arterial-and time-specific repression of leukocyte recruitment to plaques upon inhibition of CCR2 (81). Timed CCR2 blocking at nighttime (ZT17) decreased arterial myeloid cell recruitment and atherosclerotic lesion formation, whereas the neutralization at daytime (ZT5) had no effect, suggesting again the importance of chrono-pharmacology-based approaches (81).…”
Section: Targeting the Circadian Properties Of Neutrophils For Therapymentioning
confidence: 99%
“…Other studies tested the possibility of targeting the circadian properties of neutrophils and monocytes in atherosclerosis, by showing arterial-and time-specific repression of leukocyte recruitment to plaques upon inhibition of CCR2 (81). Timed CCR2 blocking at nighttime (ZT17) decreased arterial myeloid cell recruitment and atherosclerotic lesion formation, whereas the neutralization at daytime (ZT5) had no effect, suggesting again the importance of chrono-pharmacology-based approaches (81). Finally, targeting pro-migratory factors VCAM-1, ICAM-1 and CD49d during inflammatory challenge with LPS affected neutrophil trafficking and blunted inflammation (71).…”
Section: Targeting the Circadian Properties Of Neutrophils For Therapymentioning
confidence: 99%
“…Indeed, 24-h rhythms in immune cell trafficking have further consequences both in disease and treatment. For example, myeloid cell recruitment to atherosclerotic lesions oscillates, presenting a peak at the onset of the resting phase, while myeloid cell adhesion to microvascular beds happens with opposite phase (Winter et al, 2018). Hence, time-of-day specific inhibition of leukocyte recruitment provides means to treat atherosclerotic lesions without affecting inflammatory processes in the microcirculation (Winter et al, 2018).…”
Section: Clock-controlled Physiology Of Immune Cells Via Epigenetic Mmentioning
confidence: 99%
“…For example, myeloid cell recruitment to atherosclerotic lesions oscillates, presenting a peak at the onset of the resting phase, while myeloid cell adhesion to microvascular beds happens with opposite phase (Winter et al, 2018). Hence, time-of-day specific inhibition of leukocyte recruitment provides means to treat atherosclerotic lesions without affecting inflammatory processes in the microcirculation (Winter et al, 2018). In this scenario, it would be interesting to determine which epigenetic components of the circadian clock are involved in mediating time of day-specific immune cell trafficking and recruitment, as they could provide new therapeutic targets for diseases involving the immune system, and foundation to design chronotherapeutic strategies.…”
Section: Clock-controlled Physiology Of Immune Cells Via Epigenetic Mmentioning
confidence: 99%
“…In murine models of induced atherosclerosis using Apoe À/À mice on a high-fat diet, the adhesion and invasion of neutrophils and monocytes into atherosclerotic plaques depends on CCR2 and exhibits a daily rhythm, peaking in the morning in mice [48,49]. Moreover, rhythmic expression of the corresponding chemokine CCL2 in neutrophils is relevant in this scenario, and this depends on myeloid BMAL1 [49].…”
Section: Atherosclerosismentioning
confidence: 99%